Additional antiproteinuric effect of ultrahigh dose candesartan: A double-blind, randomized, prospective study

Schmieder, R., Klingbeil, A., Fleischmann, E., Veelken, R. and Delles, C. (2005) Additional antiproteinuric effect of ultrahigh dose candesartan: A double-blind, randomized, prospective study. Journal of the American Society of Nephrology, 16(10), pp. 3038-3045. (doi: 10.1681/ASN.2005020138)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Delles, Professor Christian
Authors: Schmieder, R., Klingbeil, A., Fleischmann, E., Veelken, R., and Delles, C.
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Journal of the American Society of Nephrology
ISSN:1046-6673

University Staff: Request a correction | Enlighten Editors: Update this record